WSLCB Board Chair David Postman provided an opening keynote speech reflecting on his work and the status of the agency before answering questions of concern to conference attendees.
The board said farewell to the agency public health education liaison and approved revisions to the scoring regime for criminal history background checks on license application and renewal.
Along with a rulemaking update and public hearing, an attorney brought up allegations that their client’s products contained synthesized cannabinoids and asked if a recall had been issued.
Task force members heard progress reports from work group leaders and WSLCB licensing staff while the public voiced complaints about the pace of task force work and the absence of the former co-chair.
The board received a short briefing on cannabis rulemaking, adopted a permanent ban on vitamin E acetate, and heard from a public eager to support farmers and consumers.
Board members voted to restart rulemaking on synthesized cannabinoids and heard directly from two advocates for the practice amongst many more otherwise opposed.
During a hearing on tier 1 canopy and public comment, licensees and citizens spoke to perceived limitations of the Joints for Jabs program, hemp biomass, and market structure.
The board chair responded to public comments on incentivizing coronavirus vaccination, the safety of converting hemp distillate into THC, and inaction towards business normalization.
The Board proposed rules to double tier 1 producer canopy and heard comments calling for incentivized medical cannabis production and regulation of delta-8-THC.
In addition to a rulemaking review, the meeting featured several public comments from cannabis farmers concerned about the impact cannabinoids derived from hemp CBD were having in the state’s cannabis market.